Company: INMB
Filing Date: 2025-06-16
Form Type: S-8
Source: 0001213900-25-054427
Chunk: 9

Company: Inmune Bio, Inc.
Filing Date: 2025-06-16
Form: S-8
Chunk 9
---
 selling stockholder, the nature of any position, office or
other material relationship, if any, which the selling stockholder has had, within the past three years, with us or with any of our predecessors
or affiliates, and the number of shares of our common stock beneficially owned by the selling stockholder before this offering. Except
as otherwise indicated, the selling stockholders are past or present employees or consultants of the Company. The number of shares owned
are those beneficially owned, as determined under the rules of the SEC, and the information is not necessarily indicative of beneficial
ownership for any other purpose. Under these rules, beneficial ownership includes any shares of common stock as to which a person
has sole or shared voting power or investment power and any shares of common stock which the person has the right to acquire within 60
days through the exercise of any option, warrant or right, through conversion of any security or pursuant to the automatic termination
of a power of attorney or revocation of a trust, discretionary account or similar arrangement. None of the selling stockholders is a broker-dealer
or an affiliate of a broker-dealer. Percentage of ownership is based on 23,379,796 shares of common stock outstanding on May 31, 2025.

We have assumed all shares of common stock reflected
on the table will be sold from time to time in the offering covered by this reoffer prospectus. Because the selling stockholders
may offer all or any portion of the shares of common stock listed in the table below, no estimate can be given as to the amount of those
shares of common stock covered by this reoffer prospectus that will actually be held by the selling stockholders upon the termination
of the offering. Selling stockholders may choose not to sell any of the shares of common stock registered herein.

<div align='center'>3</div>

|                            |     |                              |     | Number of Shares      
 Beneficially Owned    
 Prior to Offering (1) |            |     |             |      |   |     | Number of    
 Shares Being |           |    |     | Number of Shares   
 Beneficially Owned 
 After Offering     |           |     |             |     |   |
| Selling Stockholder        |     | Position                     |     | Number                |            |     | Percent (%) |      |   |     | Offered      |           |    |     | Number             |           |     | Percent (%) |     |   |
| Raymond J. Tes